TEVA R&D Expense Growth
Teva Pharmaceutical Industries Limited American Depositary Shares · R&D Expense Growth
TEVA R&D Expense Growth
Latest reported-3.98%period ending
TEVA FY R&D Growth (YoY) (0.00% → -3.98%)
Latest values, visible window
High-resolution chart · PNG
TEVA r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -3.981% | |
| 10.703% | |
| 13.7232% | |
| -23.4004% | |
| -39.019% | |
| 77.6238% | |
| -16.7354% | |
| -34.3615% | |
| -12.4586% | |
| 38.4262% | |
| 2.4866% | |
| 4.2747% | |
| 5.236% | |
| 23.8356% | |
| 17.3633% | |
| 16.3342% | |
| 2.0356% | |
| 35.284% | |
| 17.3737% | |
| 34.1827% | |
| 9.013% | |
| 58.5012% | |
| 29.3939% | |
| 53.8132% | |
| 2.58% | |
| 27.7767% | |
| 20.1791% | |
| 4.4479% | |
| 3.8217% | |
| 98.7342% | |
| -13.6612% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |